| Literature DB >> 26239293 |
S L Spain1, I Pedroso1, N Kadeva1, M B Miller2, W G Iacono2, M McGue2, E Stergiakouli3, G Davey Smith3, M Putallaz4, D Lubinski5, E L Meaburn6, R Plomin7, M A Simpson1.
Abstract
Although individual differences in intelligence (general cognitive ability) are highly heritable, molecular genetic analyses to date have had limited success in identifying specific loci responsible for its heritability. This study is the first to investigate exome variation in individuals of extremely high intelligence. Under the quantitative genetic model, sampling from the high extreme of the distribution should provide increased power to detect associations. We therefore performed a case-control association analysis with 1409 individuals drawn from the top 0.0003 (IQ >170) of the population distribution of intelligence and 3253 unselected population-based controls. Our analysis focused on putative functional exonic variants assayed on the Illumina HumanExome BeadChip. We did not observe any individual protein-altering variants that are reproducibly associated with extremely high intelligence and within the entire distribution of intelligence. Moreover, no significant associations were found for multiple rare alleles within individual genes. However, analyses using genome-wide similarity between unrelated individuals (genome-wide complex trait analysis) indicate that the genotyped functional protein-altering variation yields a heritability estimate of 17.4% (s.e. 1.7%) based on a liability model. In addition, investigation of nominally significant associations revealed fewer rare alleles associated with extremely high intelligence than would be expected under the null hypothesis. This observation is consistent with the hypothesis that rare functional alleles are more frequently detrimental than beneficial to intelligence.Entities:
Mesh:
Year: 2015 PMID: 26239293 PMCID: PMC4650257 DOI: 10.1038/mp.2015.108
Source DB: PubMed Journal: Mol Psychiatry ISSN: 1359-4184 Impact factor: 15.992
Figure 1Extreme sampling of the high cognitive ability cohort. Distribution of general cognitive ability, measured on a standardised IQ scale (mean 100, s.d. 15), of the high cognitive ability cohort (HiQ, n=1409, top panel) and the control cohort (MTFS, n=3253, lower panel). The red lines illustrate the expected distribution of IQ scores with unbiased sampling.
Evaluation of the I/D ratio across four MAF ranges (0–0.01, 0.01–0.05, 0.05–0.15 and 0.15–0.50) and two thresholds of nominal significance in the case–control analysis (P CC <0.01 and P CC <0.001)
| Z | P | |||||||
|---|---|---|---|---|---|---|---|---|
| 0–0.01 | 0.01 | 467 | 3.396 | 6.400 | 1.764 | 2.652 (0.271) | −3.282 | 0.001 |
| 0–0.01 | 0.001 | 73 | 8.000 | 32.159 | 3.000 | 4.861 (0.697) | −2.668 | 0.008 |
| 0.01–0.05 | 0.01 | 62 | 2.211 | 1.435 | 1.144 | 0.473 (0.369) | 1.819 | 0.069 |
| 0.01– 0.05 | 0.001 | 6 | 6.000 | 2.818 | 2.585 | 1.035 (1.222) | 1.268 | 0.205 |
| 0.05–0.15 | 0.01 | 31 | 1.000 | 1.231 | 0.000 | 0.209 (0.510) | −0.410 | 0.682 |
| 0.05–0.15 | 0.001 | 2 | 0.500 | 1.703 | −1.000 | 0.307 (1.211) | −1.079 | 0.280 |
| 0.15–0.50 | 0.01 | 60 | 0.903 | 1.098 | −0.147 | 0.075 (0.416) | −0.533 | 0.594 |
| 0.15–0.50 | 0.001 | 6 | 0.667 | 1.552 | −0.585 | 0.103 (1.264) | −0.544 | 0.586 |
Abbreviations: I/D, increaser/decreaser; MAF, minor allele frequency; SNP, single-nucleotide polymorphism. The expected I/D ratios were calculated using 1000 permutations of the phenotype to determine the null distribution. The chi-square PI/D values assess the difference between the observed and expected I/D ratios.